XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Fuze
Common Stock
Common Stock
Fuze
Additional Paid-in Capital
Additional Paid-in Capital
Fuze
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Mar. 31, 2023     114,659,000          
Beginning balance at Mar. 31, 2023 $ 99,906   $ 115   $ 905,635   $ (12,927) $ (792,917)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under stock plans (in shares)     3,535,000          
Issuance of common stock under stock plans 0   $ 3   (3)      
Stock-based compensation expense 18,559       18,559      
Issuance of common stock under stock plans, less withholding, related to Fuze acquisition (in shares)       1,038,000        
Issuance of common stock under stock plans, related to Fuze Acquisition   $ 0   $ 1   $ (1)    
Unrealized investment gain (loss) 290           290  
Foreign currency translation adjustment 1,441           1,441  
Net income (loss) (15,327)             (15,327)
Ending balance (in shares) at Jun. 30, 2023     119,232,000          
Ending balance at Jun. 30, 2023 104,869   $ 119   924,190   (11,196) (808,244)
Beginning balance (in shares) at Mar. 31, 2023     114,659,000          
Beginning balance at Mar. 31, 2023 99,906   $ 115   905,635   (12,927) (792,917)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Unrealized investment gain (loss) 281              
Net income (loss) (44,001)              
Ending balance (in shares) at Dec. 31, 2023     123,220,000          
Ending balance at Dec. 31, 2023 109,672   $ 123   956,005   (9,538) (836,918)
Beginning balance (in shares) at Jun. 30, 2023     119,232,000          
Beginning balance at Jun. 30, 2023 104,869   $ 119   924,190   (11,196) (808,244)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under stock plans (in shares)     1,784,000          
Issuance of common stock under stock plans 0   $ 2   (2)      
ESPP share issuance (in shares)     843,000          
ESPP share issuance 2,366   $ 1   2,365      
Stock-based compensation expense 14,940       14,940      
Unrealized investment gain (loss) 7           7  
Foreign currency translation adjustment (4,320)           (4,320)  
Net income (loss) (7,452)             (7,452)
Ending balance (in shares) at Sep. 30, 2023     121,859,000          
Ending balance at Sep. 30, 2023 110,410   $ 122   941,493   (15,509) (815,696)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under stock plans (in shares)     1,361,000          
Issuance of common stock under stock plans 0   $ 1   (1)      
Stock-based compensation expense 14,513       14,513      
Unrealized investment gain (loss) (16)           (16)  
Foreign currency translation adjustment 5,987           5,987  
Net income (loss) (21,222)             (21,222)
Ending balance (in shares) at Dec. 31, 2023     123,220,000          
Ending balance at Dec. 31, 2023 $ 109,672   $ 123   956,005   (9,538) (836,918)
Beginning balance (in shares) at Mar. 31, 2024 125,193,573   125,194,000          
Beginning balance at Mar. 31, 2024 $ 101,958   $ 125   973,895   (11,553) (860,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under stock plans (in shares)     2,769,000          
Issuance of common stock under stock plans 0   $ 3   (3)      
Stock-based compensation expense 13,279       13,279      
Unrealized investment gain (loss) (5)           (5)  
Foreign currency translation adjustment (354)           (354)  
Net income (loss) (10,290)             (10,290)
Ending balance (in shares) at Jun. 30, 2024     127,963,000          
Ending balance at Jun. 30, 2024 $ 104,588   $ 128   987,171   (11,912) (870,799)
Beginning balance (in shares) at Mar. 31, 2024 125,193,573   125,194,000          
Beginning balance at Mar. 31, 2024 $ 101,958   $ 125   973,895   (11,553) (860,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Unrealized investment gain (loss) (5)              
Net income (loss) $ (21,811)              
Ending balance (in shares) at Dec. 31, 2024 131,472,684   131,473,000          
Ending balance at Dec. 31, 2024 $ 113,013   $ 131   1,008,072   (12,870) (882,320)
Beginning balance (in shares) at Jun. 30, 2024     127,963,000          
Beginning balance at Jun. 30, 2024 104,588   $ 128   987,171   (11,912) (870,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under stock plans (in shares)     1,479,000          
Issuance of common stock under stock plans 0   $ 2   (2)      
ESPP share issuance (in shares)     1,075,000          
ESPP share issuance 1,683   $ 1   1,682      
Stock-based compensation expense 9,721       9,721      
Foreign currency translation adjustment 8,363           8,363  
Net income (loss) (14,543)             (14,543)
Ending balance (in shares) at Sep. 30, 2024     130,517,000          
Ending balance at Sep. 30, 2024 109,812   $ 131   998,572   (3,549) (885,342)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under stock plans (in shares)     1,034,000          
Issuance of common stock under stock plans (1)       (1)      
Common shares withheld for settlement of taxes in connection with equity-based compensation (in shares)     (78,000)          
Common shares withheld for settlement of taxes in connection with equity-based compensation (205)       (205)      
Stock-based compensation expense 9,706       9,706      
Unrealized investment gain (loss) 0              
Foreign currency translation adjustment (9,321)           (9,321)  
Net income (loss) $ 3,022             3,022
Ending balance (in shares) at Dec. 31, 2024 131,472,684   131,473,000          
Ending balance at Dec. 31, 2024 $ 113,013   $ 131   $ 1,008,072   $ (12,870) $ (882,320)